UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

GRANYLOMONOCYTIC COLONY-FORMING CELLS OF HUMAN FETAL LIVER 55

Pediatric research, 1997-05, Vol.41 (5), p.752-752

1997

Volltextzugriff (PDF)

IMMUNOPHENOTYPICAL CHARACTERISTICS OF HUMAN FETAL LIVER CELLS 75

Pediatric research, 1997-05, Vol.41 (5), p.757-757

1997

Volltextzugriff (PDF)

Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1163-1172

2016

Volltextzugriff (PDF)

Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma

The Journal of immunology (1950), 2003-12, Vol.171 (12), p.6891-6899

2003

Volltextzugriff (PDF)

Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy

Blood, 2020-05, Vol.135 (21), p.1870-1881

2020

Volltextzugriff (PDF)

PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells

PloS one, 2016-07, Vol.11 (7), p.e0159341

2016

Volltextzugriff (PDF)

In T-cell lines dually sensitized with antigens from EBV and CMV or from EBV and WT1 the T-cells specific for CMV or WT1 are often restricted by hla alleles that differ from those restricting T-cells specific for EBV

Cytotherapy (Oxford, England), 2019-05, Vol.21 (5), p.S28-S28

2019

Volltextzugriff (PDF)

T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells

Bone marrow transplantation (Basingstoke), 2015-06, Vol.50 Suppl 2 (S2), p.S43-S50

2015

Volltextzugriff (PDF)

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

The Journal of clinical investigation, 2020-02, Vol.130 (2), p.733-747

2020

Volltextzugriff (PDF)

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Oncoimmunology, 2018-01, Vol.7 (8), p.e1461305-e1461305

2018

Volltextzugriff (PDF)

Treatment with Banked 3rd Party Donor Derived Virus Specific T Cells: The Advantages of Pre-Defined HLA restriction and Epitope Specificity

Cytotherapy (Oxford, England), 2020-05, Vol.22 (5), p.S135-S135

2020

Volltextzugriff (PDF)

Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction

Bone marrow transplantation (Basingstoke), 2019-08, Vol.54 (Suppl 2), p.759-764

2019

Volltextzugriff (PDF)

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1

Nature biotechnology, 2015-10, Vol.33 (10), p.1079-1086

2015

Volltextzugriff (PDF)

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

Blood, 2010-12, Vol.116 (23), p.5045-5049

2010

Volltextzugriff (PDF)

In vivo Imaging and Quantitation of Adoptively Transferred Human Antigen-Specific T Cells Transduced to Express a Human Norepinephrine Transporter Gene

Cancer research (Chicago, Ill.), 2007-12, Vol.67 (24), p.11959-11969

2007

Volltextzugriff (PDF)

Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1+ leukemias

Blood, 2012-08, Vol.120 (8), p.1633-1646

2012

Volltextzugriff (PDF)

Case Report: Cytomegalovirus-specific T-lymphocyte infusion for resistant cytomegalovirus retinitis

Frontiers in ophthalmology, 2023-07, Vol.3, p.1131674

2023

Volltextzugriff (PDF)

Dual-Sensitized T-Cells Responding to EBV Blcl and Either CMVpp65 or WT-1 Peptide Pools Have Distinct or Shared HLA Restrictions That May Depend on the Presenting HLA Alleles

Blood, 2018-11, Vol.132 (Supplement 1), p.4596-4596

2018

Volltextzugriff (PDF)

Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy

Clinical cancer research, 2024-04, Vol.30 (8), p.1555

2024

Volltextzugriff (PDF)

Updated Efficacy and Safety of Tabelecleucel in Patients with Epstein-Barr Virus-Positive (EBV+) Leiomyosarcomas (LMS)

Blood, 2022-11, Vol.140 (Supplement 1), p.7524-7526

2022

Volltextzugriff (PDF)

Durable responses to 3rd party viral specific T cells mediated by different patterns of engraftment

Cytotherapy (Oxford, England), 2019-05, Vol.21 (5), p.S26-S26

2019

Volltextzugriff (PDF)

Targeting the intracellular WT1 oncogene product with a therapeutic human antibody

Science translational medicine, 2013-03, Vol.5 (176), p.176ra33

2013

Volltextzugriff (PDF)

Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e002752

2021

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Humans
(32)
Life Sciences & Biomedicine
(31)
Animals
(14)
Mice
(14)
Female
(13)
Hematology
(12)
Male
(11)
T-Lymphocytes - Immunology
(11)
Hematology, Oncology And Palliative Medicine
(10)
Immunology
(10)
Oncology
(10)
Transplantation
(10)
Biological And Medical Sciences
(8)
Cytomegalovirus
(8)
Adult
(7)
Immunotherapy
(7)
T Cells
(7)
T-Lymphocytes, Cytotoxic - Immunology
(7)
Adoptive Transfer
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GRANYLOMONOCYTIC COLONY-FORMING CELLS OF HUMAN FETAL LIVER 55

IMMUNOPHENOTYPICAL CHARACTERISTICS OF HUMAN FETAL LIVER CELLS 75

Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections

Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma

Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells

In T-cell lines dually sensitized with antigens from EBV and CMV or from EBV and WT1 the T-cells specific for CMV or WT1 are often restricted by hla alleles that differ from those restricting T-cells specific for EBV

T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Treatment with Banked 3rd Party Donor Derived Virus Specific T Cells: The Advantages of Pre-Defined HLA restriction and Epitope Specificity

Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

In vivo Imaging and Quantitation of Adoptively Transferred Human Antigen-Specific T Cells Transduced to Express a Human Norepinephrine Transporter Gene

Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1+ leukemias

Case Report: Cytomegalovirus-specific T-lymphocyte infusion for resistant cytomegalovirus retinitis

Dual-Sensitized T-Cells Responding to EBV Blcl and Either CMVpp65 or WT-1 Peptide Pools Have Distinct or Shared HLA Restrictions That May Depend on the Presenting HLA Alleles

Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy

Updated Efficacy and Safety of Tabelecleucel in Patients with Epstein-Barr Virus-Positive (EBV+) Leiomyosarcomas (LMS)

Durable responses to 3rd party viral specific T cells mediated by different patterns of engraftment

Targeting the intracellular WT1 oncogene product with a therapeutic human antibody

Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer

Suchergebnisse filtern